Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice

Behavioural Pharmacology - Tập 19 Số 1 - Trang 71-75 - 2008
Mikhail Kalinichev1, Simon T. Bate2, Sara Coggon3, Declan N.C. Jones
1to Mikhail Kalinichev, PhD, In vivo Neurobiology, Psychiatry CEDD, GlaxoSmithKline, Third Avenue, Harlow, Essex CM19 5 AW, UK
2Statistical Sciences, GlaxoSmithKline plc, New Frontiers Science Park, Harlow, Essex, UK
3Present address: Drug Metabolism and Pharmacokinetics, UCB, Granta Park, Great Abington, Cambridge CB21 6GS, UK.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bouwknecht, 2002, Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains, Behav Brain Res, 136, 489, 10.1016/S0166-4328(02)00200-0

Brase, 1977, Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains, J Pharmacol Exp Ther, 201, 368

Cabib, 2002, The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype, Behav Brain Res, 130, 103, 10.1016/S0166-4328(01)00422-3

Cook, 2004, Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice, Pharmacol Biochem Behav, 77, 309, 10.1016/j.pbb.2003.11.002

Geter-Douglass, 1999, Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice, Psychopharmacology, 146, 280, 10.1007/s002130051118

Harkin, 2001, Modulation of MK-801-induced behaviour by noradrenergic agents in mice, Psychopharmacology, 154, 177, 10.1007/s002130000630

Jentsch, 1999, The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia, Neuropsychopharmacology, 20, 201, 10.1016/S0893-133X(98)00060-8

Jones, 1996, Effect of exposure to novelty on brain monoamines in C57BL/6 and DBA/2 mice, Physiol Behav, 59, 361, 10.1016/0031-9384(95)02010-1

Leriche, 2003, The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade, Neuropharmacology, 45, 174, 10.1016/S0028-3908(03)00145-X

Liljequist, 1991, Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice, Eur J Pharmacol, 195, 55, 10.1016/0014-2999(91)90381-Y

Marks, 1983, Genetics of nicotine response in four inbread strains of mice, J Pharmacol Exp Ther, 226, 291

Martin, 1997, MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride, Eur J Pharmacol, 335, 107, 10.1016/S0014-2999(97)01188-6

Nilsson, 2001, A behavioural pattern analysis of hypoglutamatergic mice-effects of four different antipsychotic agents, J Neural Transm, 108, 1181, 10.1007/s007020170008

Ninan, 1999, Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine, Eur J Pharmacol, 368, 1, 10.1016/S0014-2999(98)00982-0

Tang, 2002, Home cage activity and behavioral performance in inbred and hybrid mice, Behav Brain Res, 136, 555, 10.1016/S0166-4328(02)00228-0

Tricklebank, 1989, The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor, Eur J Pharmacol, 167, 127, 10.1016/0014-2999(89)90754-1

Westfall, 1999., Multiple comparisons and multiple tests using the SAS system

Wu, 2005, Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice, Psychopharmacology, 177, 256, 10.1007/s00213-004-1944-1